Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Dermatovenerol Croat ; 30(1): 49-53, 2022 Jul.
Article in English | MEDLINE | ID: mdl-36153719

ABSTRACT

Skin changes in patients with diabetic foot (DF) are relatively common. The most frequent lesions feature papillae or cilia of various forms. The condition known as "verrucous skin lesions on the feet in diabetic neuropathy" (VSLDN) occurs in patients with distal diabetic sensorimotor neuropathy and is commonly located in places of high mechanical pressure. However, there is a scarcity of published data on the diagnosis and treatment of VSLDN. Our paper describes various types of VSLDN skin pathology, summarizes the diagnostic procedure options available, and documents the experience of our diabetic foot clinic in applying short-term VSLDN therapies as part of routine podiatric practice.


Subject(s)
Diabetes Mellitus , Diabetic Foot , Diabetic Neuropathies , Warts , Diabetic Foot/diagnosis , Diabetic Foot/etiology , Diabetic Foot/therapy , Diabetic Neuropathies/complications , Diabetic Neuropathies/diagnosis , Foot/pathology , Humans , Skin/pathology , Warts/pathology
2.
Acta Dermatovenerol Croat ; 22(4): 291-3, 2014.
Article in English | MEDLINE | ID: mdl-25580790

ABSTRACT

Hidradenitis suppurativa (HS) is a chronic, inflammatory disease characterized by recurring abscesses, nodules, and fistulas predominantly in the area of the groin and axillae. The association between HS and Crohn's disease (CD) has already been documented. We report on a case of a patient with CD associated HS, refractory to multiple local and systemic agents.A complete resolution of both diseases was finally achieved after treatment with adalimumab. Our case report supports the co-occurrence of both diseases and suggests that adalimumab approved for CD might also be a safe and effective therapeutic option in the treatment of HS.


Subject(s)
Adalimumab/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Crohn Disease/drug therapy , Hidradenitis Suppurativa/drug therapy , Chronic Disease , Crohn Disease/complications , Female , Hidradenitis Suppurativa/complications , Humans , Middle Aged
3.
Acta Dermatovenerol Croat ; 21(4): 219-23, 2013.
Article in English | MEDLINE | ID: mdl-24476607

ABSTRACT

Levels of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and tumor necrosis factor-α (TNF-α) may influence wound healing and wound closure in non-healing wounds. The aim of the study was to test the hypothesis that hydrogencalcium salts of oxidized cellulose change the production of matrix metalloproteinases (MMPs) and TNF-α, wound size and number of bacterial strains in non-healing wounds. We analyzed MMP-2, MMP-9 and TNF-α in the wound fluid from 20 patients by ELISA every fourteen days over six weeks. Wound size, pain, wound closure and bacterial strains in the wound were also investigated. The wound size was reduced in 14 patients and pain in 16 patients. Bacterial contamination of the wound decreased significantly after treatment. The level of MMP-2 correlated with TNF-α production. The level of MMP-9 was unchanged during the healing period. We conclude that hydrogencalcium salts of oxidized cellulose have a favorable effect on the reduction of bacterial contamination, wound size and pain.


Subject(s)
Cellulose, Oxidized/pharmacology , Diabetic Foot/metabolism , Diabetic Foot/therapy , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Tumor Necrosis Factor-alpha/metabolism , Varicose Ulcer/metabolism , Varicose Ulcer/therapy , Wound Healing/physiology , Aged , Diabetic Foot/microbiology , Female , Humans , Male , Middle Aged , Varicose Ulcer/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...